InvestorsHub Logo
Followers 9
Posts 2178
Boards Moderated 0
Alias Born 05/19/2021

Re: None

Thursday, 06/20/2024 7:11:22 AM

Thursday, June 20, 2024 7:11:22 AM

Post# of 18494
What's Next in Treatments for Cancer Patients with Solid Tumors?


June 20, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future treatment of solid cancer tumors, featuring Aethlon Medical, Inc. (Nasdaq:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

Research released this year predicts, "The solid tumor therapeutics market size will grow from USD 222.71 Billion in 2023 to USD 885.44 Billion in 10 years. Increasing investments of pharmaceutical companies in Research & Development will drive the solid tumor therapeutics market's growth. North America emerged as the largest market for the global Solid Tumor Therapeutics market, accounting for 44% of the total market share globally."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News